Sulfasalazine is an anti-inflammatory and immunosuppressive drug used to treat rheumatoid arthritis, ulcerative colitis, and Crohn's disease. It works by blocking the body's immune response in the colon and intestinal tract, reducing inflammation. Sulfasalazine also slows the growth of abnormal cells that cause inflammation, pain, swelling, and damage. The global sulfasalazine market is estimated to be valued at US$ 2.32 Bn in 2024 and is expected to exhibit a CAGR ... Read more
